Adrenal suppression with inhaled corticosteroids.
作者信息
Lipworth B J
出版信息
Ann Allergy Asthma Immunol. 2001 Nov;87(5):359-61. doi: 10.1016/S1081-1206(10)62914-6.
Abstract
摘要
相似文献
1
Adrenal suppression with inhaled corticosteroids.吸入性糖皮质激素导致的肾上腺抑制
Ann Allergy Asthma Immunol. 2001 Nov;87(5):359-61. doi: 10.1016/S1081-1206(10)62914-6.
2
Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients.吸入氟尼缩松和丙酸氟替卡松对成年哮喘患者下丘脑-垂体-肾上腺轴活性的抑制作用
Ann Allergy Asthma Immunol. 2001 Nov;87(5):379-85. doi: 10.1016/S1081-1206(10)62918-3.
3
Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network.吸入性糖皮质激素的使用问题。哮喘临床研究网络。
Am J Respir Crit Care Med. 1996 Jun;153(6 Pt 1):1739-48. doi: 10.1164/ajrccm.153.6.8665030.
4
Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma.吸入性皮质类固醇丙酸氟替卡松、曲安奈德和氟尼缩松以及口服泼尼松对成年哮喘患者下丘脑-垂体-肾上腺轴的影响。
Clin Ther. 1999 Feb;21(2):353-67. doi: 10.1016/S0149-2918(00)88292-2.
5
The dull-edged sword of inhaled corticosteroids.
Chest. 1999 Oct;116(4):854-6. doi: 10.1378/chest.116.4.854.
6
Asthma and Cushing's syndrome.
Chest. 2000 Feb;117(2):593-4. doi: 10.1378/chest.117.2.593.
7
Inhaled fluticasone in asthmatic children.
Ann Allergy Asthma Immunol. 2002 Sep;89(3):328-9; author reply 329. doi: 10.1016/S1081-1206(10)61967-9.
8
High-dose inhaled steroids in asthmatic children.哮喘儿童使用高剂量吸入性类固醇
Lancet. 1996 Sep 21;348(9030):819. doi: 10.1016/S0140-6736(96)24038-3.
9
High-dose inhaled steroids in asthmatic children.哮喘儿童使用高剂量吸入性类固醇
Lancet. 1996 Sep 21;348(9030):819-20. doi: 10.1016/S0140-6736(05)65233-6.
10
Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis.吸入性糖皮质激素治疗的全身性不良反应：一项系统评价和荟萃分析。
Arch Intern Med. 1999 May 10;159(9):941-55. doi: 10.1001/archinte.159.9.941.
引用本文的文献
1
Pharmacokinetic and pharmacodynamic comparison of hydrofluoroalkane and chlorofluorocarbon formulations of budesonide.布地奈德氢氟烷烃和氯氟烷烃制剂的药代动力学和药效学比较。
Br J Clin Pharmacol. 2011 Apr;71(4):504-13. doi: 10.1111/j.1365-2125.2010.03857.x.
2
Systemic bioavailability of hydrofluoroalkane (HFA) formulations of fluticasone/salmeterol in healthy volunteers via pMDI alone and spacer.健康志愿者单用压力定量气雾剂和联用储雾罐吸入氟烷烃（HFA）布地奈德/福莫特罗制剂的全身生物利用度。
Br J Clin Pharmacol. 2010 Jun;69(6):637-44. doi: 10.1111/j.1365-2125.2010.03655.x.
3
Systemic activity of inhaled corticosteroid treatment in asthmatic children: corticotrophin releasing hormone test.吸入性皮质类固醇治疗对哮喘儿童的全身活性：促肾上腺皮质激素释放激素试验
Thorax. 2003 Mar;58(3):227-30. doi: 10.1136/thorax.58.3.227.
Zotero 插件